Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001).

Takeshi KawakamiJunki MizusawaHiroko HasegawaHiroshi ImazekiKazuki KanoYuya SatoSatoru IwasaShuji TakiguchiYukinori KurokawaYuichiro DokiNarikazu BokuTakaki YoshikawaMasanori Terashima

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2022)

Dose optimization using an S-1 dosage formula can potentially reduce grade ≥ 3 adverse events for overdosed patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
human milk
peritoneal dialysis
patient reported outcomes
preterm infants
study protocol
low birth weight